Literature DB >> 30589787

Promotion of Primary Murine Breast Cancer Growth and Metastasis by Adipose-Derived Stem Cells Is Reduced in the Presence of Autologous Fat Graft.

Simon Gebremeskel1, John Gencarelli1, Alison J Gareau1, Terry Levatte1, Anton Dugandzic B Sc1, Brent Johnston1, Michael Bezuhly1.   

Abstract

BACKGROUND: Cell-assisted lipotransfer involves enrichment of autologous fat with supraphysiologic numbers of adipose-derived stem cells to improve graft take. Adipose-derived stem cells have been shown to promote cancer progression, raising concerns over the safety of adipose-derived stem cells and cell-assisted lipotransfer in postoncologic breast reconstruction. The authors compared the effect of adipose-derived stem cells alone, cell-assisted lipotransfer, and conventional fat grafting on breast cancer growth and metastasis.
METHODS: Proliferation and migration of murine 4T1 breast cancer cells cultured in control medium or mouse adipose-derived stem cell- or fat graft-conditioned medium were assessed by flow cytometry and scratch assay, respectively. Transcription levels of arginase-1, transforming growth factor-β, and vascular endothelial growth factor were assessed in adipose-derived stem cells and fat graft by quantitative reverse transcription polymerase chain reaction. An orthotopic mouse tumor model was used to evaluate breast cancer progression and metastasis. 4T1 cells were injected into the mammary pad of female BALB/c mice. Six days later, tumors were injected with saline, adipose-derived stem cells, fat graft, or cell-assisted lipotransfer (n = 7 per group). Two weeks later, primary tumors were examined by immunohistochemistry and lung metastasis was quantified.
RESULTS: Adipose-derived stem cell-conditioned medium increased cancer cell proliferation (p = 0.03); migration (p < 0.01); and transcription of arginase-1, transforming growth factor-β, and vascular endothelial growth factor compared to fat graft-conditioned or control medium (p < 0.02). Tumor-site injection with adipose-derived stem cells alone led to increased primary tumor growth and lung metastasis compared to control, fat graft, or cell-assisted lipotransfer groups (p < 0.05). Adipose-derived stem cell injection increased CD31 vascular density in tumors (p < 0.01).
CONCLUSION: Adipose-derived stem cells alone, but not conventional fat graft or cell-assisted lipotransfer, promote breast cancer cell proliferation and invasiveness in vitro and in vivo.

Entities:  

Mesh:

Substances:

Year:  2019        PMID: 30589787     DOI: 10.1097/PRS.0000000000005142

Source DB:  PubMed          Journal:  Plast Reconstr Surg        ISSN: 0032-1052            Impact factor:   4.730


  5 in total

1.  Phenotypic and Cellular Characteristics of a Stromal Vascular Fraction/Extracellular Matrix Gel Prepared Using Mechanical Shear Force on Human Fat.

Authors:  Yuan Ye; Jingjiang Zou; Meijun Tan; Kuikui Hu; Jindou Jiang
Journal:  Front Bioeng Biotechnol       Date:  2021-02-26

2.  The Impact of Human Lipoaspirate and Adipose Tissue-Derived Stem Cells Contact Culture on Breast Cancer Cells: Implications in Breast Reconstruction.

Authors:  Asim Ejaz; Katherine S Yang; Kaushik P Venkatesh; Somaiah Chinnapaka; Lauren E Kokai; J Peter Rubin
Journal:  Int J Mol Sci       Date:  2020-12-01       Impact factor: 5.923

3.  The oncological safety of autologous fat grafting: a systematic review and meta-analysis.

Authors:  Rodrigo Goncalves; Bruna Salani Mota; Bruno Sobreira-Lima; Marcos Desidério Ricci; José Maria Soares; Alexandre Mendonça Munhoz; Edmund Chada Baracat; José Roberto Filassi
Journal:  BMC Cancer       Date:  2022-04-11       Impact factor: 4.430

Review 4.  Effect of Breast Cancer and Adjuvant Therapy on Adipose-Derived Stromal Cells: Implications for the Role of ADSCs in Regenerative Strategies for Breast Reconstruction.

Authors:  Ritihaas Surya Challapalli; Roisin M Dwyer; Niall McInerney; Michael J Kerin; Aoife J Lowery
Journal:  Stem Cell Rev Rep       Date:  2020-09-14       Impact factor: 5.739

Review 5.  Cancer-associated adipocytes: emerging supporters in breast cancer.

Authors:  Chongru Zhao; Min Wu; Ning Zeng; Mingchen Xiong; Weijie Hu; Wenchang Lv; Yi Yi; Qi Zhang; Yiping Wu
Journal:  J Exp Clin Cancer Res       Date:  2020-08-12
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.